Log In
Print this Print this


Also known as: formerly NDV-3

  Manage Alerts
Collapse Summary General Information
Company NovaDigm Therapeutics Inc.
DescriptionVaccine containing a recombinant form of the Candida albicans agglutinin-like sequence 3 (ALS3) surface protein formulated with an aluminum hydroxide adjuvant
Molecular Target Agglutinin-like sequence 3 (ALS3)
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: DNA vaccine

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today